PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Th2 cytokine-mediated methimazole-induced acute liver injury in mice.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22407903 ↗2012Reported benefit

Th2 cytokine-mediated methimazole-induced acute liver injury in mice.

MouseChemical/toxinBALB/cFemaleIntraperitoneal100 microgram per mouse

Model: Methimazole-induced acute liver injury (methimazole 450 mg/kg orally; sensitised model using L-buthionine sulfoximine 3 mmol/kg intraperitoneally plus methimazole 15 mg/kg orally)

Neutralising interleukin-4 suppressed the hepatotoxic effect of methimazole, supporting a Th2 cytokine-mediated mechanism of injury.

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.